Lexicon Pharmaceuticals LXRX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $67.09M+6.7% | $63.33M-5.0% | $78.66M+128% | $50.36M+41.4% | $62.89M-34.8% | ||
| $132.57M+0.5% | $61.9M-63.9% | $66.29M-70.4% | $117.64M-57.1% | $131.95M-49.1% | ||
| $11.78M-75.2% | $2.38M-31.4% | $2.33M-19.4% | $2.18M-16.7% | $47.45M+3,009% | ||
| $276K+37.3% | $281K+21.6% | $158K-75.2% | $168K-71.3% | $201K-60.9% | ||
| $186.03M-24.3% | $101.9M-58.6% | $122.53M-54.4% | $145.08M-54.8% | $245.81M-32.6% | ||
| $1.75M-24.0% | $1.86M-25.0% | $1.98M-7.2% | $2.13M+9.1% | $2.31M+25.2% | ||
| $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | $44.54M0.0% | ||
| $268.82M-9.7% | $184.99M-38.0% | $205.93M-35.9% | $225.58M-39.6% | $297.67M-28.7% | ||
| $3M-72.0% | $3.08M-79.2% | $3.8M-73.3% | $5.9M-51.7% | $10.69M+32.5% | ||
| —— | —— | —— | —— | —— | ||
| $9.9M-91.1% | $20.87M-53.9% | $21.72M-39.7% | $34.84M+25.0% | $110.69M+373% | ||
| $49.68M-15.3% | $49.41M-50.7% | $56.51M-43.4% | $56.11M-43.6% | $58.64M-41.3% | ||
| $65.96M-62.2% | $77.45M-49.2% | $85.77M-39.9% | $96.14M-27.9% | $174.64M+36.1% | ||
| 450M0.0% | 450M+123,867% | 450M0.0% | 450M0.0% | 450M+50.0% | ||
| -$2.02B-1.3% | -$2.02B-2.6% | -$2B-3.5% | -$1.99B-6.5% | -$1.99B-9.8% | ||
| $202.86M+64.9% | $107.54M-26.3% | $120.16M-32.7% | $129.44M-46.1% | $123.03M-57.4% | ||
| $268.82M-9.7% | $184.99M-38.0% | $205.93M-35.9% | $225.58M-39.6% | $297.67M-28.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Lexicon Pharmaceuticals's total assets?
- Lexicon Pharmaceuticals (LXRX) holds $268.8M in total assets, down 9.7% year over year.
- How much debt does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals carries $57.7M in total debt against $202.9M of shareholders' equity, a debt-to-equity ratio of 0.28.
- How much cash does Lexicon Pharmaceuticals have?
- Lexicon Pharmaceuticals holds $67.1M in cash and equivalents.
- Can Lexicon Pharmaceuticals cover its short-term obligations?
- Its current ratio is 18.79 — current assets exceed current liabilities.
- Where does Lexicon Pharmaceuticals's balance sheet data come from?
- Every line is extracted from Lexicon Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
